Peroxisome proliferator-activated receptors in the regulation of female reproductive functions

Folia Histochemica et Cytobiologica

Volumn 53, Issue 3, 2015, Pages 189-200

  Bogacka, Iwona ^a   Kurzynska, Aleksandra ^a   Bogacki, Marek ^b   Chojnowska, Katarzyna ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

Estrous cycle; Ovary; Placenta; PPARs; Pregnancy; Reproduction; Uterus

Indexed keywords

CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; STEROID;

ARTICLE; BINDING AFFINITY; EMBRYO DEVELOPMENT; FEMALE GENITAL SYSTEM FUNCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; NONHUMAN; OOCYTE MATURATION; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; PLACENTA FUNCTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; STEROIDOGENESIS; UTERINE CERVIX; ESTRUS CYCLE; FEMALE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; OVARY; PLACENTA; PREGNANCY; REPRODUCTION;

ESTROUS CYCLE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OVARY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLACENTA; PREGNANCY; REPRODUCTIVE PHYSIOLOGICAL PROCESSES;

EID: 84943621356     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.a2015.0023     Document Type: Article

References (114)

1. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650. doi:10.1038/347645a0.
2. Kliewer SA, Forman BM, Blumberg B et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 1994;91:7355–7359. doi:10.1073/pnas.91.15.7355.
3. Dreyer C, Krey G, Keller H et al. Control of peroxisomal beta-oxi-dation pathway by a novel family of nuclear hormone receptors. Cell. 1992;68:879–887. doi:10.1016/0092-8674(92)90031-7.
4. Janani C, Ranjitha Kumari BD. PPAR gamma gene — a review. Diabetes Metab Syndr. 2015;9:46–50. doi:10.1016/j.dsx.2014.09.015.
5. Lalloyer F, Staels B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2010;30:894–899. doi:10.1016/j.dsx.2014.09.015.
6. Viswakarma N, Jia Y, Bai L et al. Coactivators in PPAR-regu-lated gene expression. PPAR Res. 2010;2010:250126. doi:10.1155/2010/250126.
7. Abbas A, Blandon J, Rude J et al. PPAR-g agonist in treatment of diabetes:cardiovascular safety considerations. Cardiovasc Hematol Agents Med Chem. 2012;10:124–134. doi:10.2174/187152512800388948.
8. Nestler JE, Stovall D, Akhter N et al. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 2002;77:209–215. doi:10.1016/S0015-0282(01)02963-6.
9. Barak Y, Nelson MC, Ong E et al. PPARg is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585–595. doi:10.1016/S1097-2765(00)80209-9.
10. Barak Y, Liao D, He W et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA. 2002;99:303–308. doi:10.1073/pnas.012610299.
11. Lim H, Dey SK. PPAR delta functions as a prostacyclin re­ceptor in blastocyst implantation. Trends Endocrinol Metab. 2000;11:137–142. doi:10.1016/S1043-2760(00)00243-5.
12. Yessoufou A, Hichami A, Besnard P et al. Peroxisome pro­liferator-activated receptor alpha deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus:Modulation of T cell differentiation. Endocrinology. 2006;147:4410–4418. doi:10.1210/en.2006-0067.
13. Bogazzi F, Russo D, Locci MT et al. Peroxisome proliferator-activated receptor (PPAR)gamma is highly expressed in normal human pituitary gland. J Endocrinol Invest. 2005;28:899–904. doi:10.1007/BF03345321.
14. Froment P, Fabre S, Dupont J et al. Expression and functional role of peroxisome proliferator-activated receptor-gam­ma in ovarian folliculogenesis in the sheep. Biol Reprod. 2003;69:1665–1674. doi:10.1677/joe.1.06667.
15. Sarruf DA, Yu F, Nguyen HT et al. Expression of peroxisome proliferator-activated receptor-gamma in key neuronal sub­sets regulating glucose metabolism and energy homeostasis. Endocrinology. 2009;150:707–712. doi:10.1210/en.2008-0899.
16. Heaney AP, Fernando M, Melmed S. PPAR-gamma receptor ligands:novel therapy for pituitary adenomas. J Clin Invest. 2003;111:1381–1388. doi:10.1172/JCI200316575.
17. Winczyk K, Kunert-Radek J, Gruszka A et al. Effects of rosigli-tazone-peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett. 2009;30:107–110. PMID:19300395.
18. Sharma S, Sharma PM, Mistry DS et al. PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice. Biol Reprod. 2011;84:466–475. doi:10.1095/biolreprod.110.088005.
19. Cui Y, Miyoshi K, Claudio E et al. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem. 2002;277:17830–1785. doi:10.1074/jbc.M200186200.
20. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod. 2002;66:190–198. doi:10.1095/biolreprod66.1.190.
21. Zerani M, Maranesi M, Brecchia G et al. Evidence for a lu­teotropic role of peroxisome proliferator-activated receptor gamma:expression and in vitro effects on enzymatic and hor­monal activities in corpora lutea of pseudopregnant rabbits. Biol Reprod. 2013;88:62. doi:10.1095/biolreprod.112.107383.
22. Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function — implications for regulating steroidogenesis, differentiation, and tissue remodeling. Re­prod Biol Endocrinol. 2005;3:41. doi:10.1186/1477-7827-3-41.
23. Dupont J, Chabrolle C, Ramé C et al. Role of the peroxisome proliferator-activated receptors, adenosine monophos­phate-activated kinase, and adiponectin in the ovary. PPAR Res. 2008;2008:176275. doi:10.1155/2008/176275.
24. Komar CM, Curry TE Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudo­pregnant rats. Biol Reprod. 2002;66:1531–1539. doi:10.1095/biolreprod66.5.1531.
25. Viergutz T, Loehrke B, Poehland R et al. Relationship between different stages of the corpus luteum and the ex­pression of the peroxisome proliferator-activated receptor gamma protein in bovine large lutein cells. J Reprod Fertil. 2000;118:153–161. doi:10.1530/reprod/118.1.153.
26. Bogacka I, Bogacki M. The quantitative expression of peroxi­some proliferator activated receptor (PPAR) genes in porcine endometrium through the estrous cycle and early pregnancy. J Physiol Pharmacol. 2011;62:559–565. PMID:22204804.
27. Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-ac­tivated receptor-gamma induces regression of endome­trial explants in a rat model of endometriosis. Fertil Steril. 2004;82:1008–1013. doi:10.1016/j.fertnstert.2004.02.148.
28. Froment P, Gizard F, Defever D et al. Peroxisome prolif-erator-activated receptors in reproductive tissues:from ga­metogenesis to parturition. J Endocrinol. 2006;189:199–209. doi:10.1677/joe.1.06667.
29. Chen Q, Sun X, Chen J et al. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol. 2009;7:147. doi:10.1186/1477-7827-7-147.
30. Minge CE, Ryan NK, Van Der Hoek KH et al. Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macro­phages. Biol Reprod. 2006;74:153–160. doi:10.1095/biolre­prod.105.043729.
31. Lovekamp-Swan T, Chaffin CL. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Mol Cell Endocrinol. 2005;233:15–24. doi:10.1016/j.mce.2005.01.011.
32. Tinfo N, Komar C. Potential role for peroxisome proliferator-ac­tivated receptor gamma in regulating luteal lifespan in the rat. Reproduction. 2007;133:187–196. doi:10.1530/REP-06-0134.
33. Margeli A, Kouraklis G, Theocharis S. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis. Angiogenesis. 2003;6:165–169. doi:10.1023/B:A­GEN.0000021377.13669.c0.
34. Seto-Young D, Paliou M, Schlosser J et al. Direct thiazoli­dinedione action in the human ovary:insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab. 2005;90:6099–6105. doi:10.1210/jc.2005-0469.
35. Komar CM, Braissant O, Wahli W et al. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology. 2001;142:4831–4838. doi:10.1210/endo.142.11.8429.
36. Rak-Mardyła A, Karpeta A. Rosiglitazone stimulates peroxi­some proliferator-activated receptor gamma expression and directly affects in vitro steroidogenesis in porcine ovarian follicles. Theriogenology. 2014;82:1–9. doi:10.1016/j.theriog­enology.2014.02.016.
37. Gasic S, Bodenburg Y, Nagamani M et al. Troglitazone inhib­its progesterone production in porcine granulosa cells. Endo­crinology. 1998;139:4962–4926. doi:10.1210/endo.139.12.6385.
38. Willis D, Mason H, Gilling-Smith C et al. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302–309. doi:10.1210/jcem.81.1.8550768.
39. Hara S, Takahashi T, Igarashi H et al. Peroxisome proliferator-activated receptor-g agonists prevent Tumor Necro­sis Factor-a-mediated inhibition of FSH-induced follicle development and estradiol production in a preantral follicle culture system. J Mamm Ova Res. 2014;31:2–11. doi:10.1274/jmor.31.2.
40. Shaikh N, Mukherjee A, Shah N et al. Peroxisome proliferator activated receptor gamma gene variants influence susceptibil­ity and insulin related traits in Indian women with polycystic ovary syndrome. J Assist Reprod Genet. 2013;30:913–921. doi:10.1007/s10815-013-0025-y.
41. Yang J, Gong H, Liu W et al. The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome. Int J Clin Exp Pathol. 2013;6:1894–1902. PMID:24040456.
42. Löhrke B, Viergutz T, Shahi SK et al. Detection and func­tional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endo­crinol. 1998;159:429–439. doi:10.1677/joe.0.1590429.
43. Kurzynska A, Bogacki M, Chojnowska K et al. Peroxisome proliferator activated receptor ligands affect progesterone and 17b-estradiol secretion by porcine corpus luteum during early pregnancy. J Physiol Pharmacol. 2014;65:709–717. PMID:25371531.
44. Seto-Young D, Avtanski D, Strizhevsky M et al. Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regula­tory protein in human ovarian cells. J Clin Endocrinol Metab. 2007;92:2232–2239. doi:10.1210/jc.2006-1935.
45. Puttabyatappa M, Vandevoort CA, Chaffin CL. hCG-induced down-regulation of PPARg and liver X receptors promotes periovulatory progesterone synthesis by macaque granulosa cells. Endocrinology. 2010;151:5865–5872. doi:10.1210/en.2010-0698.
46. Fan W, Yanase T, Morinaga H et al. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X recep­tor inhibits aromatase transcription via nuclear factor-kappaB. Endocrinology. 2005;146:85–92. doi:10.1210/en.2004-1046.
47. Toda K, Okada T, Miyaura C et al. Fenofibrate, a ligand for PPAR alpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse. J Lipid Res. 2003;44:265–270. doi:10.1194/jlr.M200327-JLR200.
48. MacLaren LA, Guzeloglu A, Michel F et al. Peroxisome proliferator-activated receptor (PPAR) expression in cul­tured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production. Domest Anim Endocrinol. 2006;30:155–169. doi:10.1016/j.domaniend.2005.07.003.
49. Cammas L, Reinaud P, Bordas N et al. Developmental regula­tion of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period. Reproduction. 2006;131:917–927. doi:10.1530/rep.1.00799.
50. Nishimura K, Yamauchi N, Chowdhury VS et al. Expres­sion of peroxisome proliferator-activated receptor isoforms in the rat uterus during early pregnancy. Cell Tissue Res. 2011;345:275–284. doi:10.1007/s00441-011-1208-4.
51. Ulbrich SE, Schulke K, Groebner AE et al. Quantitative charac­terization of prostaglandins in the uterus of early pregnant cattle. Reproduction. 2009;138:371–382. doi:10.1530/REP-09-0081.
52. Lord E, Murphy BD, Desmarais JA et al. Modulation of peroxisome proliferator-activated receptor delta and gamma transcripts in swine endometrial tissue during early gestation. Reproduction. 2006;131:929–942. doi:10.1530/rep.1.00657.
53. Bogacka I, Bogacki M, Wasielak M. The effect of embryo presence on the expression of peroxisome proliferator activat­ed receptor (PPAR) genes in the porcine reproductive system during periimplantation. Acta Vet Hung. 2013;61:405–415. doi:10.1556/AVet.2013.013.
54. Klein C, Troedsson MH. Maternal recognition of pregnan­cy in the horse:a mystery still to be solved. Reprod Fertil. 2011;23:952–963. doi:10.1071/RD10294.
55. Waclawik A. Novel insights into the mechanisms of pregnan­cy establishment:regulation of prostaglandin synthesis and signaling in the pig. Reproduction. 2011;142:389–399. doi:10.1530/REP-11-0033.
56. Weems CW, Weems YS, Randel RD. Prostaglandins and reproduction in female farm animals. Vet J. 2006;171:206–228. doi:10.1016/j.tvjl.2004.11.014.
57. Kang HJ, Hwang SJ, Yoon JA et al. Activation of peroxisome proliferators-activated receptor d (PPARd) promotes blas­tocyst hatching in mice. Mol Hum Reprod. 2011;17:653–660. doi:10.1093/molehr/gar030.
58. Morawska-Pucinska E, Szymanska M, Blitek A. Expres­sion profile and role of prostacyclin receptor (PTGIR) in peri-implantation porcine conceptuses. Theriogenology. 2014;82:546–556. doi:10.1016/j.theriogenology.2014.05.014.
59. Meade EA, McIntyre TM, Zimmerman GA et al. Peroxisome proliferators enhance cyclooxygenase-2 expression in epi­thelial cells. J Biol Chem. 1999;274:8328–8334. doi:10.1074/jbc.274.12.8328.
60. Sharma I, Dhawan V, Saha SC et al. In vitro effects of per­oxisome proliferator-activated receptor-g ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells. Fertil Steril. 2011;95:829–831. doi:10.1016/j.fertnstert.2010.09.008.
61. Sheldrick EL, Derecka K, Marshall E et al. Peroxisome-pro­liferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus. Biochem J. 2007;406:175–183. doi:10.1042/BJ20070089.
62. Ackerman WE, Zhang XL, Rovin BH et al. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. Biol Reprod. 2005;73:527–535. doi:10.1095/biolreprod.104.039032.
63. Lim H, Gupta RA, Ma WG et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 1999;13:1561–1574. doi:10.1101/gad.13.12.1561.
64. Bogacka I, Bogacki M, Kurzyńska A et al. The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2a production by porcine endometrium. Reprod Biol. 2013;13:309–316. doi:10.1016/j.repbio.2013.10.001.
65. Bogacka I, Bogacki M, Gaglewska M et al. In vitro effect of peroxisome proliferator activated receptor (PPAR) ligands on prostaglandin E2 synthesis and secretion by porcine endome­trium during the estrous cycle and early pregnancy. J Physiol Pharmacol. 2013;64:47–54. PMID:23568971.
66. Lim H, Dey SK. A novel pathway of prostacyclin signal­ing-hanging out with nuclear receptors. Endocrinology. 2002;143:3207–3210. doi:10.1210/en.2002-220159.
67. Gillio-Meina C, Phang SH, Mather JP et al. Expression patterns and role of prostaglandin-endoperoxide synthases, prostaglandin E synthases, prostacyclin synthase, prostacy­clin receptor, peroxisome proliferator-activated receptor delta and retinoid x receptor alpha in rat endometrium during artificially-induced decidualization. Reproduction. 2009;137:537–552. doi:10.1530/REP-08-0294.
68. Okada H, Tsuzuki T, Shindoh H et al. Regulation of decidualization and angiogenesis in the human endometrium:mini review. J Obstet Gynaecol Res. 2014;40:1180–1187. doi:10.1111/jog.12392.
69. Franczak A, Zmijewska A, Kurowicka B et al. Interleukin 1b induces synthesis and secretion of prostaglandin E2 in the porcine uterus during various periods of pregnancy and the estrous cycle. J Physiol Pharmacol. 2010;61:733–742. PMID:21224505.
70. Gunin AG, Bitter AD, Demakov AB et al. Effects of per­oxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. J Endocrinol. 2004;182:229––239. doi:10.1677/joe.0.1820229.
71. Keller H, Givel F, Perroud M et al. Signaling cross-talk be­tween peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol. 1995;9:794–804. doi:10.1210/me.9.7.794.
72. Makrigiannakis A, Minas V, Kalantaridou SN et al. Hormonal and cytokine regulation of early implantation. Trends Endo­crinol Metab. 2006;17:178–185. doi:10.1016/j.tem.2006.05.001.
73. Bogacki M, Wasielak M, Zięcik A. The role of cytokines and adhesion molecules in maternal recognition and establish­ment of pregnancy in pigs. J Anim Feed Sci. 2005;14:581–594.
74. Weiss G, Maseelall P, Schott LL et al. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2009;91:201–216. doi:10.1016/j.fertn­stert.2007.11.025.
75. Szymanowski K, Niepsuj-Biniaś J, Dera-Szymanowska A et al. An influence of immunomodulation on Th1 and Th2 immune response in endometriosis in an animal model. Biomed Res Int. 2013;2013:849492. doi:10.1155/2013/849492.
76. Minge CE, Robker RL, Norman RJ. PPAR gamma:coordi­nating metabolic and immune contributions to female fertility. PPAR Res. 2008;2008:243791. doi:10.1155/2008/243791.
77. Wanichkul T, Han S, Huang RP et al. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. Fertil Steril. 2003;79:763–769. doi:10.1016/S0015-0282(02)04835-5.
78. McKinnon B, Bersinger NA, Mueller MD. Peroxisome prolif­erating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones. Fertil Steril. 2012;97:657–664. doi:10.1016/j.fertnstert.2011.12.001.
79. Bogacka I, Bogacki M, Boruszewska D et al. Expression of peroxisome proliferator activated receptor (PPAR) genes in porcine endometrium exposed in vitro to IL-6 and INFg. Reprod Biol. 2012;12:157–170. doi:10.1016/S1642-431X(12)60083-7.
80. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82–86. doi:10.1038/34184.
81. Schaiff WT, Bildirici I, Cheong M et al. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor sig­naling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab. 2005;90:4267–4275. doi:10.1210/jc.2004-2265.
82. Fournier T, Tsatsaris V, Handschuh K et al. PPARs and the pla­centa. Placenta. 2007;28:65–76. doi:10.1016/j.placenta.2006.04.009.
83. Fournier T, Guibourdenche J, Handschuh K et al. PPARγand human trophoblast differentiation. J Reprod Immunol. 2011;90:41–49. doi:10.1016/j.jri.2011.05.003.
84. Capparuccia L, Marzioni D, Giordano A et al. PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma. Mol Hum Reprod. 2002;8:574–579. doi:10.1093/molehr/8.6.574.
85. Asami-Miyagishi R, Iseki S, Usui M et al. Expression and function of PPARgamma in rat placental development. Bio­chem Biophys Res Commun. 2004;315:497–501. doi:10.1016/j.bbrc.2004.01.074.
86. Degrelle SA, Murthi P, Evain-Brion D et al. Expression and localization of DLX3, PPARG and SP1 in bovine trophoblast during binucleated cell differentiation. Placenta. 2011;32:917––920. doi:10.1016/j.placenta.2011.08.014.
87. Wang Q, Fujii H, Knipp GT. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta. 2002;23:661–671. doi:10.1053/plac.2002.0855.
88. Holdsworth-Carson SJ, Permezel M, Riley C et al. Peroxisome proliferator-activated receptors and retinoid X receptor-al­pha in term human gestational tissues:tissue specific and labour-associated changes. Placenta. 2009;30:176–186. doi:10.1016/j.placenta.2008.11.013.
89. Kubota N, Terauchi Y, Miki H et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597–609. doi:10.1016/S1097-2765(00)80210-5.
90. Nadra K, Quignodon L, Sardella C et al. PPAR gamma in placental angiogenesis. Endocrinology. 2010;151:4969–4981. doi:10.1210/en.2010-0131.
91. Zhu Y, Kan L, Qi C et al. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interact­ing protein (PRIP) as a coactivator for PPAR. J Biol Chem. 2000;275:13510–13516. doi:10.1074/jbc.275.18.13510.
92. Shalom-Barak T, Nicholas JM, Wang Y et al. Peroxisome proliferator-activated receptor gamma controls Muc1 tran­scription in trophoblasts. Mol Cell Biol. 2004;24:10661–10669. doi:10.1128/MCB.24.24.10661-10669.2004.
93. Tarrade A, Schoonjans K, Guibourdenche J et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology. 2001;142:4504–4514. doi:10.1210/endo.142.10.8448.
94. Schaiff WT, Carlson MG, Smith SD et al. Peroxisome prolif­erator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endo­crinol Metab. 2000;85:3874–3881. doi:10.1210/jc.85.10.3874.
95. Tarrade A, Schoonjans K, Pavan L et al. PPAR gamma/RXR alpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab. 2001;86:5017–5024. doi:10.1210/jcem.86.10.7924.
96. Fournier T, Thérond P, Handschuh K et al. PPARgamma and early human placental development. Curr Med Chem. 2008;15:3011–3024. doi:10.2174/092986708786848677.
97. Bilban M, Haslinger P, Prast J et al. Identification of novel trophoblast invasion-related genes:heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology. 2009;150:1000–1013. doi:10.1210/en.2008-0456.
98. Handschuh K, Guibourdenche J, Guesnon M et al. Modulation of PAPP-A expression by PPAR gamma in human first trimester trophoblast. Placenta. 2006;27:127–134. doi:10.1016/j.placenta.2005.10.012.
99. Handschuh K, Guibourdenche J, Tsatsaris V et al. Human chorionic gonadotropin produced by the invasive tropho­blast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. Endocrinology. 2007;148:5011–5019. doi:10.1210/en.2007-0286.
100. Hutter S, Knabl J, Andergassen U et al. The Role of PPARs in placental immunology:A systematic review of the litera­ture. PPAR Res. 2013;2013:970276. doi:10.1155/2013/970276.
101. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and pros­taglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology. 2005;146:3334–3342. doi:10.1210/en.2005-0406.
102. Keelan JA, Blumenstein M, Helliwell RJ et al. Cytokines, prostaglandins and parturition — a review. Placenta. 2003;24(A):33–46. doi:10.1053/plac.2002.0948.
103. Duttaroy AK. Transport of fatty acids across the human pla­centa:a review. Prog Lipid Res. 2009;48:52–61. doi:10.1016/j.plipres.2008.11.001.
104. Zhang S, Regnault TR, Barker PL et al. Placental adaptations in growth restriction. Nutrients. 2015;7:360–389. doi:10.3390/nu7010360.
105. Xu Y, Wang Q, Cook TJ et al. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator acti­vated receptor on pregnancy and fetal outcomes. J Pharm Sci. 2007;96:2582–2606. doi:10.1002/jps.20973.
106. Bildirici I, Roh CR, Schaiff WT et al. The lipid droplet-as­sociated protein adipophilin is expressed in human tropho­blasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab. 2003;88:6056–6062. doi:10.1210/jc.2003-030628
107. Nadra K, Anghel SI, Joye E et al. Differentiation of tropho­blast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol Cell Biol. 2006;26:3266–3281. doi:10.1128/MCB.26.8.3266-3281.2006.
108. Pakrasi PL, Jain AK. Cyclooxygenase-2 derived PGE2 and PGI2 play an important role via EP2 and PPAR delta re­ceptors in early steps of oil induced decidualization in mice. Placenta. 2008;29:523–530. doi:10.1016/j.placenta.2008.03.001.
109. Mohan M, Malayer JR, Geisert RD et al. Expression patterns of retinoid X receptors, retinaldehyde dehydrogenase, and peroxisome proliferator activated receptor gamma in bovine preattachment embryos. Biol Reprod. 2002;66:692–700. doi:10.1095/biolreprod66.3.692.
110. Rees WD, McNeil CJ, Maloney CA. The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res. 2008;2008:459030. doi:10.1155/2008/459030.
111. Lindegaard ML, Nielsen LB. Maternal diabetes causes coor­dinated down-regulation of genes involved with lipid metabo­lism in the murine fetal heart. Metabolism. 2008;57:766–773. doi:10.1016/j.metabol.2008.01.016.
112. Martínez N, White V, Kurtz M et al. Activation of the nuclear receptor PPARa regulates lipid metabolism in foetal liver from diabetic rats:implications in diabetes-induced foetal overgrowth. Diabetes Metab Res Rev. 2011;27:35–46. doi:10.1002/dmrr.1151.
113. Park KS, Lee RD, Kang SK et al. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-depen­dent pathway. Exp Cell Res. 2004;297:424–433. doi:10.1016/j.yexcr.2004.03.034.
114. Malm T, Mariani M, Donovan LJ et al. Activation of the nuclear receptor PPARb is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation. J Neuroinflammation. 2015;12:7. doi:10.1186/s12974-014-0229-9.